baber/WOPTO huggingface dataset:
Patent AU-2002318699-B2 (AU)
Title: Cream for treatment of skin injured by the sun
Inventor: STARLANDER ULF
IPC: A61K47/10
Filed: 2002-06-30
Granted: 2007-01-04
Abstract: Abstract of the Disclosure This invention relates to a cream of the kind described in the preamble of claim 1 for topical treatment of visibly photodamaged skin caused by processes involving the influence of free radicals and where the cream also affects the energy production of the cells, wherein the active ingredients of the cream is carried in stabilizing cream base. The cream is characterized in 0.5% and 7% by weight d,l-alpha-lipoic acid, between 0.05 and 0.5% by weight coenzyme Q-10, between 0.001 and 3% by weight acetyl-l-carnitine hydrochloride, which constitute the active ingredients, whereby having a compound synergy effect.
Patent AU-2002347900-B2 (AU)
Title: Bronchial flow control devices and methods of use
Inventor: HUNDERTMARK RONALD
IPC: A61F2/04
Filed: 2002-10-10
Granted: 2005-12-01
Abstract: Methods and systems for lung volume reduction of a patient are described. The methods include implanting a flow control device in a bronchial passageway of the lung. The flow control device regulates fluid flow through the bronchial passageway and includes a valve protector that at least partially surrounds a valve member. The valve protector has sufficient rigidity to maintain the shape of the valve member against compression.
Patent AU-2002352090-B2 (AU)
Title: Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
Inventor: FFOWST CAMILLA
IPC: C07D403/14
Filed: 2002-12-18
Granted: 2008-05-15
Abstract: The present invention provides the combined use of acryloyl distamycin derivatives, in particular alpha-bromo- and alpha-chloro-acryloyl distamycin derivatives of formula (I), as set forth in the specification, and a protein kinase (serine/threonine and tyrosine kinases) inhibitor, in the treatment of tumors. Also provided is the use of the said combinations in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogenesis.
Patent AU-2003215734-B2 (AU)
Title: Improvements in or relating to a container
Inventor: JOWETT LOUISE
IPC: A47L15/44
Filed: 2003-03-05
Granted: 2008-02-21
Abstract: A blister pack (1) for use with a device, the device being for receiving, holding and dispensing a detergent composition (or additive) into an automatic dishwashing machine over a plurality of washing cycles, the device comprising a housing (10) adapted to receive said detergent composition which is introduced into said housing in the form of a plurality of unit doses (2) each separately contained in a package or compartment (4) thereof; a dosing means (18) to effect dosing of said detergent composition, the means being capable of receiving mechanical energy, sufficient for a plurality of washing cycles, applied thereto by a user, the mechanical energy being stored by locking the dosing means in a loaded position with locking means (25-27), the mechanical energy being released in a stepwise mode when said locking means is unlocked; and an opening means (30) for opening said package or compartment or for at least partly ejecting said unit dose therefrom, and wherein the dosing means is adapted to actuate the opening means, and the pack is in the form of a wheel-like plate (3) with the unit doses arranged in a circle along the circumference thereof.
Patent AU-2003221517-B2 (AU)
Title: Cytocapacity test
Inventor: STRAKA CHRISTIAN
IPC: G01N33/96
Filed: 2003-03-24
Granted: 2010-02-18
Abstract: The present invention relates to a method for determining the hematopoietic cytocapacity of a subject comprising the steps of: (a) determining the amount of leukocytes present in a blood sample obtained from a subject, wherein said subject has been subjected to administration of a single dose of G-CSF; and (b) determining the hematopoietic cytocapacity by assessing the amount of leukocytes determined instep (a) with the amount of leukocytes which have been mobilized or released in a control subject wherein said control subject.
Patent AU-2003228722-B2 (AU)
Title: Treatment of alpha-galactosidase A deficiency
Inventor: BOROWSKI MARIANNE
IPC: C12Q1/54
Filed: 2003-04-25
Granted: 2009-06-25
Abstract: The invention provides methods of treating alpha galactosidase A deficiency. Dosage forms, methods of administration, and methods of analyzing human alpha galactosidase A are also included.
Patent AU-2003249268-B2 (AU)
Title: Oral composition providing enhanced oral hygiene properties
Inventor: SZELES LORI H
IPC: A61K38/48
Filed: 2003-07-16
Granted: 2009-05-28
Abstract: An antiplaque oral care composition having enhanced oral hygiene and organoleptic properties is provided. The composition contains an enzyme and a cyclodextrin. Papain and other proteolytic enzymes may be preferred. The resulting composition has more favorable organoleptic properties than a comparative composition containing only the enzyme.
Patent AU-2003284994-B2 (AU)
Title: Methods to prevent tumor recurrence by blockade of TGF-Beta
Inventor: TERABE MASAKI
IPC: C12N5/09
Filed: 2003-10-24
Granted: 2009-11-12
Abstract: Methods are provided herein to prevent a tumor recurrence in a subject, involving administering to the subject an agent that blocks the TGF-beta signaling pathway. In one embodiment, the agent inhibits the immunosuppressive effects of TGF-beta. Also provided is a method of enhancing an immune respond in a subject to inhibit recurrence of a tumor by administering an agent which blocks the TGF-beta signaling pathway. A method of enhancing the activity of an immune cell to inhibit recurrence of a tumor by contacting a TGF-beta receptor-expressing cell with an agent which blocks the TGF-beta signaling pathway is also provided, as are methods of screening for an agent that inhibits or measurably reduces the recurrence of a tumor.
Patent AU-2003296083-B2 (AU)
Title: Vaccines comprising polynucleotides
Inventor: SHIKU HIROSHI
IPC: A61K39/00
Filed: 2003-12-24
Granted: 2007-08-02
Abstract: A composition containing an expression vector which encodes an antigen recognized by CD4+ helper T lymphocyte and an antigen recognized by CD8+ cytotoxic T lymphocyte (CTL) (in particular, a tumor-specific antigen, a tumor-associated antigen or a cell-associated antigen), preferably containing an expression vector encoding interferon-gamma. Specific examples of the antigen recognized by CD4+ helper T lymphocyte include cancer/testis antigens such as NY-ESO-1, while specific examples of the antigen recognized by CD8+ cytotoxic T lymphocyte (CTL) (in particular, a tumor-specific antigen, a tumor-associated antigen or a cell-associated antigen) include HER-2/neu and cancer/testis antigens such as NY-ESO-1, MAGE and SAGE.
Patent AU-2005263381-B2 (AU)
Title: Ice-containing products
Inventor: CHAMBERLAIN DOROTHY MARGARET
IPC: A23G9/44
Filed: 2005-06-20
Granted: 2008-08-14
Abstract: An unaerated ice-containing product is provided which comprises at -18°C, a first population of frozen particles having a particle size of greater than 0.5 mm and a second population of frozen particles having a mean particle size such that the ratio of the mean particle size for the first population to the mean particle size for the second population is greater than 10 and less than 100, wherein the ratio of the weight of the first population of particles to the weight of the second population is from 2:3 to 9:1 and the first population and second population together provide at least 90% of the frozen particles present in the product. A process for making such products is also provided.
Patent AU-2006201577-B2 (AU)
Title: Graphical user interface including a pop up window for an ocular surgical system
Inventor: BOUKHNY MIKHAIL
IPC: G06F19/00
Filed: 2006-04-13
Granted: 2010-11-04
Abstract: A graphical user interface for use in phacoemulsification surgical systems that allows a user to select different pulse modes by touching portions of the display screen. The user interface includes first and second display elements. One display element includes a representation of the on-time of the pulses, and the other display element includes a representation of the off-time. The representations show how the on-time and off- time change relative to a position of a controller, such as a foot pedal. The representation show a constant time, or that a time increases or decreases as the foot pedal is pressed. To select a pulse mode, a user can scroll through different pulse representations by touching the screen at the display elements. The selected pulse mode can be continuous, pulse, burst, or a combination or derivation thereof.
Patent AU-2006246410-B2 (AU)
Title: Multi-axial seamed papermaking fabric and method
Inventor: LEE HENRY
IPC: D03D25/00
Filed: 2006-04-24
Granted: 2009-07-09
Abstract: A multi-axial seamed base fabric is provided that is formed from a spirally wound fabric strip having a width less than an overall width of the fabric that is joined together along neighboring adjacent edges of the strip to form a fabric tube. The fabric strip includes a plurality of generally linearly extending vertically stacked pairs of machine direction (MD) warp yarns interwoven with cross-machine direction (CMD) weft yarns in a repeat pattern which maintains the vertically stacked alignment of the paired MD warp yarns. The fabric tube includes an upper layer and a lower layer formed from the spirally wound fabric strip that are adjacent to one another in the base fabric. The ends of the base fabric are formed by CMD folds in the fabric tube, with the MD warp yarns of each of the upper and lower layers being in a generally vertically stacked alignment within both of the layers adjacent to the ends to provide at least some continuously extending ones of the outer warp yarns between the upper and lower layers at the folds. Seaming loops are formed from at least some of the continuously extending ones of the outer MD yarns located at the CMD folds in the fabric tube. A method of producing such a fabric is also provided.
Patent AU-2006263759-B2 (AU)
Title: Breath sampling device
Inventor: KVASNIK FRANK
IPC: G01N33/497
Filed: 2006-06-13
Granted: 2012-02-16
Abstract: A hollow container defining a sample chamber is formed of at least two parts (30, 40) which fit together and have apertures (34, 36; 44, 46) therein. One of the parts (40) is displaceable relative to the other part (30) between a first relative disposition of the parts in which the apertures are open so as to provide a clear path for air to pass through the container and a second relative disposition of the parts in which the apertures are closed so that there is no path for air to pass through and a volume of air is trapped in the chamber. In one version the part (40) is axially moveable relative to the other part (30). In another version where the parts are tubular one of the parts is rotatable relative to the other. In other versions the apertures are in respective end closures and end caps located thereover and the end caps are rotatable to align the apertures and open the chamber for air to pass through. In other versions, one of the parts is pivotable or bendable relative to the other to open or close the respective apertures. In yet other versions one part is rotatable on an axis transverse to the axis of the other part to open or close the respective apertures.
Patent AU-2006322025-B2 (AU)
Title: Porous calcium phosphate bone material
Inventor: STRUNK MICHAEL
IPC: A61F2/00
Filed: 2006-12-06
Granted: 2013-08-15
Abstract: Porous calcium phosphate implant compositions that approximate the chemical composition of natural bone mineral are provided. In addition to calcium phosphate, the compositions include an effervescent agent to promote the formation of interconnected pores and a cohesiveness agent to maintain the shape and hardness of the hardened composition. When introduced at an implant site, the calcium phosphate compositions are remodeled into bone. Methods for using the calcium phosphate compositions, e.g., to repair or replace bone, are also provided.
Patent AU-2007220920-B2 (AU)
Title: Humanized anti-ghrelin antibodies
Inventor: SUBRAMANIAM DANISE ROGERS
IPC: A61P3/06
Filed: 2007-02-21
Granted: 2012-08-02
Abstract: Provided are humanized monoclonal antibodies, and antigen-binding portions thereof, which bind acylated and unacylated human ghrelin. Such antibodies are useful for neutralizing ghrelin activity and treating disorders in which ghrelin activity is detrimental, including obesity and related disorders, and various cancers.
Patent AU-2007231546-B2 (AU)
Title: Amplification of DNA fragments
Inventor: RAND KEITH
IPC: C12Q1/68
Filed: 2007-03-28
Granted: 2012-04-26
Abstract: A method for detecting a nucleic acid molecule having a target sequence adjacent a 3' terminus is provided. Also provided is a method for differentiating nucleic acid molecules having a target sequence adjacent a 3' terminus from nucleic acid molecules in which the same sequence is embedded within the molecule.
Patent AU-2007239066-B2 (AU)
Title: Describing and querying discrete regions of flash storage
Inventor: PATEL SACHIN CHIMAN
IPC: G06F12/02
Filed: 2007-02-23
Granted: 2011-07-28
Abstract: A flash driver can be used by file systems and other applications to determine more detailed attributes and properties, such as region geometry, that describe the underlying flash component. This allows a file system, for example, to be made aware of each flash region and its properties. The file system may then be optimized to more efficiently utilize the flash component. These optimizations may lead to increased component longevity and better read/write performance.
Patent AU-2007252223-B2 (AU)
Title: Compact low noise efficient blower for CPAP devices
Inventor: SWEENEY PETER JOHN
IPC: F04D3/00
Filed: 2007-05-24
Granted: 2009-04-23
Abstract: The present invention relates to a centrifugal blower (100) comprising a substantially axially symmetrical housing, a motor (140) , a shaft (160), and at least three impellers (150, 152, 154) connected to the shaft. The blower is a three-stage blower and there is at least one impeller per stage.
Patent AU-2007277157-B2 (AU)
Title: Fungicidal azocyclic amides
Inventor: SHAPIRO RAFAEL
IPC: A61K31/454
Filed: 2007-07-27
Granted: 2013-01-31
Abstract: Disclosed are compounds of Formulae 1, 1A, 1B and 1C including all geometric and stereoisomers,
Patent AU-2007307427-B2 (AU)
Title: Composition for treating atopic dermatitis comprising extracts of Bamboo and Scutellaria
Inventor: WOO SUNG SICK
IPC: A61K36/539
Filed: 2007-10-12
Granted: 2013-05-09
Abstract: The present invention relates to a composition comprising of plant extract as an active component, specifically, Bamboo extract and Scutellaria extract, for the treatment and prevention of atopic dermatitis. The present invention is a natural ingredient obtained from a plant. The present invention can control immune responses by inhibiting the release of histamine and leukotrien, and thus, has effect in the treatment or prevention of allergic diseases, inflammatory diseases and skin diseases, specifically atopic dermatitis. The present invention has been proven safe and beneficial effecting the treatement of atopic dermitatis through clinical trials, and thus, can be used for the treatment and prevention of atopic dermitatis.
Patent AU-2007325780-B2 (AU)
Title: Heteroaryl amide derivatives
Inventor: LI HONGBIN
IPC: A61K31/555
Filed: 2007-11-27
Granted: 2013-05-02
Abstract: Heteroaryl amide derivatives are provided, of the Formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
Patent AU-2008209566-B2 (AU)
Title: 23-substituted bile acids as TGR5 modulators and methods of use thereof
Inventor: PELLICCIARI ROBERTO
IPC: A61P1/16
Filed: 2008-01-18
Granted: 2012-09-20
Abstract: The invention relates to compounds of Formula A: (A) or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof. The compounds of Formula A are TGR5 modulators useful for the treatment of various diseases, including obesity, insulin sensitivity, inflammation, cholestasis, and bile desaturation.
Patent AU-2008244736-B2 (AU)
Title: Grass based avian deterrent
Inventor: ROLSTON MAURICE PHILLIP
IPC: A01N63/30
Filed: 2008-04-28
Granted: 2013-10-24
Abstract: The invention relates to uses and methods relating to grass and endophyte combinations to repel avian species from the grass and endophyte combination. In particular, methods are described to select grass and endophyte combinations in order to enhance or maximise the repellent effect. Preferred endophyte and grass combinations are described which are based on the selection methods and include AR4, AR5, AR8 and AR94 (Deposit Nos. V07/029054, V07/029055, V07/029056, V07/029057) in
Patent AU-2008259946-B2 (AU)
Title: Immunoglobulin constant region Fc receptor binding agents
Inventor: BLOCK DAVID S
IPC: A61K39/00
Filed: 2008-05-30
Granted: 2013-08-29
Abstract: IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are then screened in vitro to assess each replacements compound's efficiency at modulating immune function. Particular replacement compounds are selected for further in vivo validation and dosage/administration optimization. Finally, the replacement compounds are used to treat a wide range of diseases, including inflammatory and autoimmune diseases.
Patent AU-2008296223-B2 (AU)
Title: Azeotropic and azeotrope-like compositions of E-1,1,1,4,4,5,5,5-Octafluoro-2-pentene
Inventor: ROBIN MARK L
IPC: C09K5/04
Filed: 2008-09-05
Granted: 2013-07-04
Abstract: Azeotropic or azeotrope-like compositions are disclosed. The azeotropic or azeotrope-like compositions are mixtures of E-1,1,1,4,4,5,5,5-Octafluoro-2-pentene with methyl formate, n-pentane, 2-methylbutane, 1,1,1,3,3-pentafluorobutane, trans-1,2-dichloroethylene, 1,1,1,3,3-pentafluoropropane, dimethoxymethane, cyclopentane or Z-1,1,1,4,4,4-hexafluoro-2-butene. Also disclosed is a process of preparing a thermoplastic or thermoset foam by using such azeotropic or azeotrope-like compositions as blowing agents. Also disclosed is a process of producing refrigeration by using such azeotropic or azeotrope-like compositions. Also disclosed is a process of using such azeotropic or azeotrope-like compositions as solvents. Also disclosed is a process of producing an aerosol product by using such azeotropic or azeotrope-like compositions as propellants. Also disclosed is a process of using such azeotropic or azeotrope-like compositions as heat transfer media. Also disclosed is a process of extinguishing or suppressing a fire by using such azeotropic or azeotrope-like compositions. Also disclosed is a process of using such azeotropic or azeotrope-like compositions as dielectrics. Also disclosed is a process for the separation of a chemical compound from a mixture of two or more chemical compounds using such azeotropic or azeotrope-like compositions.
Patent AU-2008346511-B2 (AU)
Title: A method for modulating the release rate of microencapsulated actives
Inventor: BASSETTI LUCIO
IPC: A01N53/00
Filed: 2008-12-23
Granted: 2014-08-07
Abstract: A method for regulating the release rate of microencapsulated actives comprising: 1a) addition or subtraction of piperonylbutoxide (PBO), component B) to 2a) formulations A) comprising at least one microencapsulated active having agrochemical activity, optionally PBO outside the microcapsule, 3a) dilution by water of component A) and/or component B) until the active application dose, the ratio by weight PBO/active ranges from 0.1 to 80, the PBO subtraction being feasible only when the PBO is present outside the microcapsule of the formulation A).
Patent AU-2008348197-B2 (AU)
Title: Multifunctional oxidation catalysts and methods of making
Inventor: WOOD THOMAS E
IPC: B01J35/00
Filed: 2008-01-14
Granted: 2011-09-01
Abstract: Applicant discloses multifunctional, highly active oxidation catalysts and methods of making such catalysts. Such methods include providing nanoparticles comprising titanium-oxo and zinc-oxo compositions, such as crystalline anatase titania nanoparticles with zinc-oxo domains on their surfaces, and etching the nanoparticles. The method also includes depositing catalytically active gold onto the nanoparticles, by, for example, physical vapor deposition.
Patent AU-2009200790-B2 (AU)
Title: Elementary support for object display comprising a hinge polyhedral compartment
Inventor: L HOTEL FRANCOIS
IPC: G09F5/02
Filed: 2009-02-27
Granted: 2014-11-13
Abstract: ELEMENTARY SUPPORT FOR OBJECT DISPLAY COMPRISING A HINGE POLYHEDRAL COMPARTMENT DESCRIPTIVE The compartment of the support of the invention is hinged to switch between a flat folded condition and an unfolded and open functional condition to receive an object. It comprises a retractable wall (115) for holding 10 the compartment in its unfolded and open condition and elastic means (127) for biasing the holding wall in an unretracted holding position. The flattening of the compartment is done by retracting the holding wall against the action of elastic means. The pivoting holding 15 retracting wall (115) is a shoring wall between a floor face (105) and a ceiling face (103) with which they form a force descending rod. The display of the invention can serve to provide information but also objects to be displayed. Fig. 3 -204 226 219 211 207 217 218 213 209 224 208 206 233 205 231 221 220 Fig. 4
Patent AU-2009201950-B2 (AU)
Title: Screen device
Inventor: OKACHI YASUBUMI
IPC: E06B9/52
Filed: 2009-05-18
Granted: 2015-12-17
Abstract: Abstract A shrinkable and extensible screen is mounted between a pair of screen-mounting frame portions arranged bilaterally to confront each other and at least one being slidably movable. A tension member extending through the screen for supporting it in shrinking and extending directions is routed in the screen-mounting frame portions. The tension member is extracted at the portion close to the central portion from the upper end portion of the slidably movable screen-mounting frame portions, to the outside on the side opposite to the screen mounting side. Fig. 1
Patent AU-2009207494-B2 (AU)
Title: Polychromic substances and their use
Inventor: JARVIS ANTHONY N
IPC: C09B57/00
Filed: 2009-01-22
Granted: 2011-08-11
Abstract: A compound which undergoes a colour change upon irradiation, and which has the general structure: X-C≡C-C≡C-Y-(CO)-QZ wherein X is H, alkyl or -Y-(CO)-QW; each Y is the same or a different divalent alkylene group; Q is O, S or NR; R is H or alkyl; W is H, alkyl or Z; each Z is the same or a different unsaturated alkyl group; and each n is 0 or 1.
Patent AU-2009212928-B2 (AU)
Title: Adjustable Bolt Assembly for Use with a Cylindrical Lock Assembly
Inventor: CONSTANTINOU JOHN
IPC: E05B63/06
Filed: 2009-09-02
Granted: 2015-12-17
Abstract: This invention relates to a bolt assembly 3 for use with a cylindrical lock 5 assembly. The bolt assembly 3 is adjustable to operate in either a relatively long backset mode or a relatively short backset mode. The bolt assembly includes a lock bolt 12 with a draw bar 15 and a tail bar 8. The relative position of the tail bar 8 with respect to the draw bar 15 is adjustable so as to adjust the mode of operation of the bolt assembly between the long back set and short 10 back set. C:adjustable bolt assembly for use with a cylindrical lock assembly 865173 q